Page last updated: 2024-09-05

erlotinib hydrochloride and Thymus Neoplasms

erlotinib hydrochloride has been researched along with Thymus Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anile, M; Bellissimo, T; Blandino, G; De Angelis, L; Diso, D; Facciolo, F; Fazi, F; Gallo, E; Ganci, F; Giangaspero, F; Marino, M; Masciarelli, S; Pescarmona, E; Petrozza, V; Pulito, C; Sacconi, A; Tito, C; Venuta, F	1
Abdullaev, Z; Beadling, C; Berman, A; Carter, CA; Corless, CL; Doyle, A; Giaccone, G; Guha, U; Kelly, R; Killian, K; Lau, CC; Liewehr, DJ; Lopez-Chavez, A; Meltzer, PS; Morrow, B; Pack, S; Raffeld, M; Rajan, A; Sandler, A; Steinberg, SM; Szabo, E; Thomas, A; Wang, Y; Warrick, A; Xi, L	1
Koshiishi, H; Takahashi, E; Takahashi, M	1

Trials

1 trial(s) available for erlotinib hydrochloride and Thymus Neoplasms

Article	Year
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Mar-20, Volume: 33, Issue:9 Topics: Adolescent; Adult; Aged; Benzimidazoles; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Class I Phosphatidylinositol 3-Kinases; ErbB Receptors; Erlotinib Hydrochloride; Female; Genes, ras; Humans; Indoles; Lapatinib; Lung Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; PTEN Phosphohydrolase; Pyrroles; Quinazolines; ras Proteins; Reproducibility of Results; Small Cell Lung Carcinoma; Sunitinib; Thymus Neoplasms; Treatment Outcome; Young Adult	2015

Article

Year

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Mar-20, Volume: 33, Issue:9

Topics: Adolescent; Adult; Aged; Benzimidazoles; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Class I Phosphatidylinositol 3-Kinases; ErbB Receptors; Erlotinib Hydrochloride; Female; Genes, ras; Humans; Indoles; Lapatinib; Lung Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; PTEN Phosphohydrolase; Pyrroles; Quinazolines; ras Proteins; Reproducibility of Results; Small Cell Lung Carcinoma; Sunitinib; Thymus Neoplasms; Treatment Outcome; Young Adult

2015

Other Studies

2 other study(ies) available for erlotinib hydrochloride and Thymus Neoplasms

Article	Year
Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation. Molecular cancer, 2017, 05-10, Volume: 16, Issue:1 Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Epigenesis, Genetic; Erlotinib Hydrochloride; Female; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Neoplasms, Glandular and Epithelial; RNA, Messenger; Thymoma; Thymus Neoplasms	2017
[A response to erlotinib hydrochloride in the case of post-operative recurrent thymoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12 Topics: Adult; Erlotinib Hydrochloride; Female; Humans; Protein Kinase Inhibitors; Quinazolines; Recurrence; Thymoma; Thymus Neoplasms	2011

Article

Year

Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation.

Molecular cancer, 2017, 05-10, Volume: 16, Issue:1

Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Epigenesis, Genetic; Erlotinib Hydrochloride; Female; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Neoplasms, Glandular and Epithelial; RNA, Messenger; Thymoma; Thymus Neoplasms

2017

[A response to erlotinib hydrochloride in the case of post-operative recurrent thymoma].

Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12

Topics: Adult; Erlotinib Hydrochloride; Female; Humans; Protein Kinase Inhibitors; Quinazolines; Recurrence; Thymoma; Thymus Neoplasms

2011